Explainer: Covid-19 treatment options in the GCC
Gulf Business|January 2021
Pharma firm Gilead Sciences is in the process of receiving authorisations for its drug remdesivir across all the Gulf states
Ayman Elsayes

With your drug remdesivir receiving FDA approval for Covid-19 treatment, what is the process for getting approval for its usage in the GCC?

The US Food and Drug Administration approval for remdesivir was granted on October 22, 2020. In the GCC, we initiated discussions with national regulatory authorities in May 2020 to identify the most appropriate regulatory pathways for the registration of remdesivir. The current authorisations are at the federal level in each of the GCC countries, with approval already received in the UAE and emergency use authorisation in place in other GCC countries including Saudi Arabia, where the process for a full marketing authorisation approval by the Saudi Food and Drug Authority is in its final step.

While Covid-19 vaccines are receiving heightened attention, are there also several treatment options undergoing trials worldwide?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM GULF BUSINESSView All

The big picture

The Journey of Humanity is the world’s largest canvas painting. Dubai-based artist Sacha Jafri raised $62m from the sale of it, all of which will now be given to charity. Here’s what it took to create one of the biggest artistic, social and philanthropic projects of its kind to date

6 mins read
Gulf Business
April 2021

Navigating the Experience Age

We have an opportunity to transform and redefine travel by exploring how virtual and real experiences might complement one another

2 mins read
Gulf Business
April 2021

Explainer: Have workplace savings plans taken off in the GCC?

Having a pension solution ensures that the employer sets aside a defined amount on a periodic basis for end of service benefits

3 mins read
Gulf Business
April 2021

Calling the right numbers

Standing apart and making a mark in the regional telecom industry has been challenging and yet rewarding, states Mountasser Hachem, founder and CEO of Monty Mobile

4 mins read
Gulf Business
April 2021

Building a golfing legacy

Indian businessman Sudesh Aggarwal will launch the inaugural Emirates Amateur Golf League – the world’s first franchise-based amateur golf league – this November in Dubai

4 mins read
Gulf Business
April 2021

Outsized ambitions

Ricardo Guadalupe, CEO of Hublot, took a Swiss watchmaker that was only known among a select few and transformed it into a larger-than-life phenomenon. Here’s how he did it

5 mins read
Gulf Business
April 2021

Phi Trends: Healthy growth for alternative therapies

The market for alternative therapies such as gene-based solutions has garnered investor interest due to advancements in recent months, states entrepreneur and investor Shailesh Dash, who shares his perspective in this monthly column

4 mins read
Gulf Business
April 2021

Primed for growth

Abu Dhabi-based Yas Holding is rapidly expanding its portfolio across key sectors such as healthcare, education and technology. Group CEO Murshed Al Redaini reveals how the company has tackled the Covid crisis and its ambitious plans for the future

4 mins read
Gulf Business
April 2021

Why are we in a digital disarray?

It’s about time all of us seriously reflect on how we break this addiction

3 mins read
Gulf Business
April 2021

Riding the wave

UAE homegrown boat manufacturing business, Gulf Craft, helmed by Mohammed Hussein Alshaali, has built itself into a world-class player – evident in the new Majesty 175 which conducted its first sea trials earlier this year

5 mins read
Gulf Business
March 2021
RELATED STORIES

US RECOMMENDS ‘PAUSE' FOR J&J SHOTS IN BLOW TO VACCINE DRIVE

The U.S. recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.

5 mins read
Techlife News
Techlife News #494

GET SMART

AI’S ROLE IN THE COVID VACCINATION PROCESS

3 mins read
The BOSS Magazine
February 2021

Coming Out Of The Chemical Closet

Neuropsychopharmacologist Carl Hart says most of what the public knows about drugs is both scary and wrong.

10+ mins read
Reason magazine
May 2021

HEMP Approval Program Now Available From UF/IFAS

OWNERS OF INDUSTRIAL HEMP GENETICS can now submit their varieties for approval by the University of Florida for legal sale within the state.

2 mins read
Central Florida Ag News
February 2021

The Covid-19 Manhattan Project

Never have so many researchers trained their minds on a single problem in so brief a time. Science will never be the same.

10+ mins read
The Atlantic
January - February 2021

Business at Its Best

With a big hand from the government, pharmaceutical companies delivered the vaccine that the world desperately needed. Here’s how something in 2020 went right for a change

10+ mins read
Bloomberg Businessweek
December 28 - January 04, 2021

PHARMACEUTICAL SUPPLY CHAIN DISRUPTIONS DUE TO THE PANDEMIC

The COVID-19 pandemic is both a public health crisis and an economic disrupter too.

6 mins read
Industry Leaders
December 2020

Vintage Pharmacy Cabinet

An Homage to the Past by Embracing the Present.

10+ mins read
Popular Woodworking
December 2020

THREE WAYS TO PREVENT BLANKET INJURIES

Of all the things your horse could injure himself with, his blanket seems an unlikely candidate. But don’t rule it out. Blanket mishaps do happen and they can be serious. Here are three things you can do to avoid them:

3 mins read
Equus
Winter 2020

COVID VACCINES: WHAT YOU NEED TO KNOW

150 labs testing life-saving shots

4 mins read
National Enquirer
November 09, 2020